F-H set to build Genzyme's profile

Biotechnology firm Genzyme Therapeutics has hired its first corporate PR support in an effort to raise the company's profile in the UK.

Fleishman-Hillard fought off competition from Hanover Communications and APCO Worldwide to land the media relations and public affairs brief.

Meanwhile, fellow Omnicom agency Bernard Hodes Group has been appointed to handle employee comms.

Genzyme is the world's third largest biotechnology company and specialises in rare inherited disorders, kidney disease, orthopaedics, transplant, cancer, and diagnostic testing.

Both agencies will report to Genzyme's government relations director Steve Bates.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in